New clinical research study on schizophrenia begins on campus

Dr. Steve Olson at the University of Minnesota is beginning a new research study to help people with schizophrenia. The study, which is currently looking for participants, will research a new investigational drug to improve cognitive functions in people with schizophrenia. Schizophrenia affects about one percent of the human population, according to the National Institute of Mental Health. That’s about 2.4 million people in the U.S. The drug that Olson is investigating is a drug that will be added onto the regimen of drugs that people with schizophrenia are already taking, instead of replacing the drugs that they are taking. Take a look at more information here.